Cardiovascular disease (CVD) is the leading cause of death in the Asia-Pacific, with over 10 million deaths in 2019 and significant economic costs. The APAC CVD Alliance is a regional multisectoral coalition focused on raising public and policy awareness of cardiovascular disease and its comorbidities in the Asia-Pacific. Established in 2022, it seeks to address specific gaps in CVD prevention and control and aims to inspire policy change across prevention, early detection, treatment, and rehabilitation. The Alliance connects patients, healthcare professionals, academia, nonprofits, media, and corporate partners to enhance cardiovascular health across the region.
Enhancing cardiovascular health in the Asia-Pacific through comprehensive care, partnerships, and advocacy for investment and healthy living.
Improve cardiovascular health and reduce the CVD burden in the Asia-Pacific for patients, societies, and economies.
Partner with patients and health systems across the care continuum of prevention, early detection, treatment, and rehabilitation.
Advocate for investment to tackle CVD and promote healthy living across all age groups.
The methodology includes a multi-pronged approach involving policy advocacy, patient-centered activities, and comprehensive research. The Alliance works closely with diverse stakeholders to create a unified strategy for cardiovascular health improvement.
Effective engagement with governments and regional forums like APEC and ASEAN has increased awareness and action on CVD in the Asia-Pacific.
The inclusion of patient voices, particularly through the APAC CVD Patients’ Roundtable, has ensured that patient needs are central to the Alliance’s initiatives.
The launch of reports and country profiles has provided valuable insights and driven cohesive action towards cardiovascular care.
